about
Functions of Cationic Host Defense Peptides in ImmunityPotential Use of Antimicrobial Peptides as Vaginal Spermicides/MicrobicidesPeptides and Peptidomimetics for Antimicrobial Drug DesignNovel formulations for antimicrobial peptidesHypothesis driven development of new adjuvants: short peptides as immunomodulatorsUltrashort cationic lipopeptides and lipopeptoids selectively induce cytokine production in macrophagesCathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulationRhodomyrtone modulates innate immune responses of THP-1 monocytes to assist in clearing methicillin-resistant Staphylococcus aureusThe Frog Skin-Derived Antimicrobial Peptide Esculentin-1a(1-21)NH2 Promotes the Migration of Human HaCaT Keratinocytes in an EGF Receptor-Dependent Manner: A Novel Promoter of Human Skin Wound Healing?Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections.Defense peptides secreted by helminth pathogens: antimicrobial and/or immunomodulator molecules?Antimicrobial activity of a C-terminal peptide from human extracellular superoxide dismutase.Synergism in dual functionality of cryptdin-2 in conjunction with antibiotics against Salmonella.Cathelicidin host defence peptide augments clearance of pulmonary Pseudomonas aeruginosa infection by its influence on neutrophil function in vivo.Perspectives for clinical use of engineered human host defense antimicrobial peptidesAntibodies fused to innate immune molecules reduce initiation of Cryptosporidium parvum infection in mice.Hydrophobicity and helicity regulate the antifungal activity of 14-helical β-peptides.A peptide of heparin cofactor II inhibits endotoxin-mediated shock and invasive Pseudomonas aeruginosa infection.Bacterial membrane activity of α-peptide/β-peptoid chimeras: influence of amino acid composition and chain length on the activity against different bacterial strains.Effective inhibition of melanoma tumorigenesis and growth via a new complex vaccine based on NY-ESO-1-alum-polysaccharide-HH2.LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalentsEvaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo.Host defence peptides: antimicrobial and immunomodulatory activity and potential applications for tackling antibiotic-resistant infections.Effect of vitamin D supplementation on Mycobacterium tuberculosis-induced innate immune responses in a Canadian Dené First Nations cohortInnate defense regulator peptide 1018 in wound healing and wound infectionCathelicidin administration protects mice from Bacillus anthracis spore challengeCathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial barrier permeabilityHuman antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates.The human antimicrobial peptide LL-37 binds directly to CsrS, a sensor histidine kinase of group A Streptococcus, to activate expression of virulence factors.Adaptive evolution of Escherichia coli to an α-peptide/β-peptoid peptidomimetic induces stable resistance.Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance?In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37Protecting the boundary: the sentinel role of host defense peptides in the skin.Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens.In vitro and in vivo synergistic effects of cryptdin 2 and ampicillin against Salmonella.Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.CecropinXJ, a silkworm antimicrobial peptide, induces cytoskeleton disruption in esophageal carcinoma cells.Inactivation of the antifungal and immunomodulatory properties of human cathelicidin LL-37 by aspartic proteases produced by the pathogenic yeast Candida albicans.OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii.Structure and function of papiliocin with antimicrobial and anti-inflammatory activities isolated from the swallowtail butterfly, Papilio xuthus.
P2860
Q26744224-21000282-B0B0-4A3D-9931-020096D608F1Q26765450-9A7CC6B8-0796-4853-AABE-EF5F7972A111Q26799959-7D3C2F10-3F1D-4F0F-858E-AE398760F45EQ26991771-261251DC-BACE-495F-820A-417D51C9E046Q27023844-52429E8D-C714-485B-AAEF-CDDA718D660DQ28485935-032D0DB4-E746-4DFD-B97F-A3CE64D51BF3Q28534617-39139665-1D91-4ED1-8A1F-32A25ABBB534Q28543877-86E71D8B-E728-47B0-9E90-FE80F2F54743Q28548287-97B63CF1-9B1F-4407-854D-9BCC22E071BDQ30151971-3401D72F-3262-4315-8304-5E6E87DBE9FDQ30564789-27F53B71-B44C-4A44-B23C-DF4A6F383D0BQ33482556-CD145E3F-1DFD-4482-B872-512AC56B62F7Q33568915-F258470A-8278-4F2C-99FF-84659B07D5ECQ33700171-5FEE1B9A-2FC0-4B83-A5CE-E3F404C7E445Q33700825-BAAE07EA-A66E-445B-B188-3C970F0CCF99Q33768898-919B02D9-053B-4CF9-A651-44F82F7E25D1Q33926906-245BB35D-AA4B-4990-A5CB-4A8DDD5AE0B8Q33927961-31C1CF43-B929-4162-81D5-8387CD365EB1Q33938698-468A7310-88DE-49C5-81EB-84ED10BA6C6AQ33994533-AAE0A5B0-FE9A-4A01-B550-9919F42055D2Q34058299-083F2B23-B2A0-43F4-AC65-D9E9FD61ADDDQ34058642-F418F02C-5D5B-44F7-8A2C-E4B32C412348Q34264486-2C132D8E-0BD3-472D-BD44-CC40802CC665Q34367177-718AB3AA-92FD-472E-950D-264F54E58D4DQ34373912-ADB76902-A235-411C-8F1B-9C036584CC1DQ34476038-1B2E70D4-C011-4983-A948-19E22DADFF06Q34501689-F4ED9B61-3A01-4005-AF9C-35A56EB62609Q34668042-6EC63517-5DF6-4971-964B-AB1F49661DF8Q34774620-BE19FD9E-8186-4F52-9C73-410A1F80E312Q34989010-32CC187C-36B6-408C-AA77-D168D6D7A46DQ35010044-EDF5AE31-3FAB-4A8E-B081-8C50067B4421Q35023257-E5023881-28D3-48AD-B2BE-F9743BD12861Q35075143-3A72D611-ECE8-45A9-BBE1-31E1340A21C2Q35105947-AAE3104A-9F9D-4DEA-B52C-FD7D7C09C6E1Q35191401-94F3153C-1380-4A38-BD70-A26322283A43Q35197365-95381A43-178C-48AE-A38E-95939CDB2884Q35224948-0D356A3C-090F-4836-93FA-4ADAE01AC843Q35609334-8403E20D-4C5B-4744-B31C-75F1AEEFEABFQ35814247-55955DFE-5E88-44DE-9F5A-B388B1A750B6Q35842107-2270F4BE-8A89-48FD-B9DE-C9DBB9E1B1AC
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Impact of LL-37 on anti-infective immunity.
@ast
Impact of LL-37 on anti-infective immunity.
@en
type
label
Impact of LL-37 on anti-infective immunity.
@ast
Impact of LL-37 on anti-infective immunity.
@en
prefLabel
Impact of LL-37 on anti-infective immunity.
@ast
Impact of LL-37 on anti-infective immunity.
@en
P2093
P2860
P50
P356
P1476
Impact of LL-37 on anti-infective immunity
@en
P2093
Monisha G Scott
Y Elaine Lau
P2860
P304
P356
10.1189/JLB.0704380
P577
2004-11-29T00:00:00Z